{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$3.10 vs. cons $3.085",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Global systemwide RevPAR growth",
      "prediction": "BEAT",
      "answer": "pred ~2.2% vs. cons 1.995%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Gross fees",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.557B vs. cons $1.555B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 global RevPAR growth",
      "prediction": "UNCHANGED",
      "answer": "guide 2.0%-3.0% vs. cons 2.516%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted EPS",
      "prediction": "LOWER",
      "answer": "guide $11.38-$11.63 vs. cons $11.663",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 gross fees",
      "prediction": "LOWER",
      "answer": "guide $5.925B-$5.985B vs. cons $6.000B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted EBITDA",
      "prediction": "LOWER",
      "answer": "guide $5.880B-$5.970B vs. cons $5.970B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2H26 U.S. & Canada demand tone",
      "prediction": "UNCHANGED",
      "answer": "guide positive but slower than 1H vs. qualitative consensus",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "LOW",
  "day5_residual_pct": 4.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 RevPAR beat supports modest revisions despite constrained FY guide",
  "day5_confidence": "LOW"
}